Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
New digital health companion uses friendly, jargon-free communication to help users better understand reports
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The new capital is expected to fund the company through 2029
The center combines rigorous scientific instruction with practical, hands-on training, equipping providers with the clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered care
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Subscribe To Our Newsletter & Stay Updated
